|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| C12Q 1/68 | (2018.01) | ||
| C07K 16/28 | (2006.01) | ||
| G01N 33/50 | (2006.01) | ||
| C12N 5/09 | (2010.01) | ||
| C12N 5/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/30 | (2006.01) |
| (11) | Number of the document | 3043181 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15198767.4 |
| Date of filing the European patent application | 2009-01-13 | |
| (97) | Date of publication of the European application | 2016-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 11324 P | 2008-01-15 | US |
| (72) |
WEISSMAN, Irving, L., US
MAJETI, Ravindra, US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS |
| MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS |